Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.

Objectives: The aim of this study is to assess the effectiveness and safety of glucocorticoid infusion pulse therapy to improve the clinical outcomes of patients with COVID-19 pneumonia with elevated inflammatory biomarkers.

Trial Design: A parallel-group quadruple-blind (participant, intervention provider, outcome assessor and data manager), randomised controlled trial.

Participants: All patients admitted to hospital due to COVID-19 pneumonia will be considered eligible.